Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Rafael launches Phase III trial of pancreatic cancer drug

Metastatic pancreatic adenocarcinoma with lepidic growth pattern. Credit: Yale Rosen.

  • Rafael Pharmaceuticals

Go Top